title: Pharmacoeconomics of Neoral, a new formulation of cyclosporine, in renal transplantation.
authors.affiliation: Department of Health Economics, Sandoz Pharma Ltd, Basel, Switzerland.
authors.forename: I
authors.initials: I
authors.lastname: Abella
mesh_terms: D000284:Administration, Oral; D002986:Clinical Trials as Topic; D003365:Costs and Cost Analysis; D016572:Cyclosporine / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006760:Hospitalization / Q000191:economics; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000191:economics* / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000191:economics* / Q000276:immunology*
chemical_list: D007166:Immunosuppressive Agents; D016572:Cyclosporine